The eRulemaking Program
03/10/2026 | Press release | Distributed by Public on 03/10/2026 07:20
Patent Extension Regulatory Review Period: Aurora EV-ICD
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket Nos. FDA-2024-E-3535 and FDA-2024-E-3536]
Determination of Regulatory Review Period for Purposes of Patent Extension; AURORA EV-ICD
Correction
In Notice Document 2026-02383, appearing on pages 5497 through 5498, in the issue of Friday, February 6, 2026, make the following correction:
On page 5497, in the second column, in the ADDRESSES section, in the 8th line, "February 6, 2026" should read "April 7, 2026".
[FR Doc. C1-2026-02383 Filed 3-9-26; 8:45 am]
BILLING CODE 0099-10-D
The eRulemaking Program published this content on March 10, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on March 10, 2026 at 13:20 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]